latest articles

MorphoSys smashes through Phase 3 trial with myelofibrosis drug champion

MorphoSys (NASDAQ:MOR) declared that a Phase 3 exploration for its drug pelabresib conquered...

Hallelujah! Buy-Rated Stocks Are On a Rampage

What a time to be alive for the stock market! The stocks are on a winning streak, driven...

Market Surges, Greenland Technologies Shares Take a Plunge

The Dow Jones index galloped ahead, gaining over 200 points at the closing bell on Monday.As the Dow...

Komatsu’s Electrifying Acquisition Sparks a Green Revolution

Komatsu has acquired American Battery Solutions (ABS) to ramp up its electrification efforts in the construction and mining...

Investor Beware: Brokers Push JPMorgan Chase & Co. (JPM) as a ‘Strong Buy’

Wall Street brokers are chirping, but should investors lend an ear to their song and dance? The average...